Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 932

1.

A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.

Alimenti A, Forbes JC, Oberlander TF, Money DM, Grunau RE, Papsdorf MP, Maan E, Cole LJ, Burdge DR.

Pediatrics. 2006 Oct;118(4):e1139-45. Epub 2006 Aug 28.

PMID:
16940166
2.

Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.

Newell ML, Borja MC, Peckham C; European Collaborative Study.

Pediatrics. 2003 Jan;111(1):e52-60.

PMID:
12509595
3.

Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy.

Lindsey JC, Malee KM, Brouwers P, Hughes MD; PACTG 219C Study Team.

Pediatrics. 2007 Mar;119(3):e681-93. Epub 2007 Feb 12.

PMID:
17296781
4.

Head growth and neurodevelopment of infants born to HIV-1-infected drug-using women.

Macmillan C, Magder LS, Brouwers P, Chase C, Hittelman J, Lasky T, Malee K, Mellins CA, Velez-Borras J.

Neurology. 2001 Oct 23;57(8):1402-11.

PMID:
11673580
5.

The neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants.

Whitehead N, Potterton J, Coovadia A.

AIDS Care. 2014 Apr;26(4):497-504. doi: 10.1080/09540121.2013.841828. Epub 2013 Oct 14.

PMID:
24125015
6.

Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG; Pediatric Spectrum of HIV Disease Consortium.

Pediatrics. 2007 Apr;119(4):e900-6. Epub 2007 Mar 12.

PMID:
17353299
7.

No relation between in-utero exposure to HAART and intrauterine growth retardation.

Briand N, Mandelbrot L, Le Chenadec J, Tubiana R, Teglas JP, Faye A, Dollfus C, Rouzioux C, Blanche S, Warszawski J; ANRS French Perinatal Cohort.

AIDS. 2009 Jun 19;23(10):1235-43. doi: 10.1097/QAD.0b013e32832be0df.

PMID:
19424054
8.

Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.

Alimenti A, Burdge DR, Ogilvie GS, Money DM, Forbes JC.

Pediatr Infect Dis J. 2003 Sep;22(9):782-9.

PMID:
14506368
9.

Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.

Noguera A, Fortuny C, Muñoz-Almagro C, Sanchez E, Vilaseca MA, Artuch R, Pou J, Jimenez R.

Pediatrics. 2004 Nov;114(5):e598-603. Epub 2004 Oct 18.

PMID:
15492359
10.

Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.

Feiterna-Sperling C, Weizsaecker K, Bührer C, Casteleyn S, Loui A, Schmitz T, Wahn V, Obladen M.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):43-51.

PMID:
17356471
11.

Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers.

Bunders MJ, Bekker V, Scherpbier HJ, Boer K, Godfried M, Kuijpers TW.

Acta Paediatr. 2005 Nov;94(11):1571-7.

PMID:
16303696
12.

[A prospective study of neurodevelopment of uninfected children born to human immunodeficiency virus type 1 positive mothers].

Gómez C, Archila ME, Rugeles C, Carrizosa J, Rugeles MT, Cornejo JW.

Rev Neurol. 2009 Mar 16-31;48(6):287-91. Spanish.

13.

Quality of life for children and adolescents: impact of HIV infection and antiretroviral treatment.

Lee GM, Gortmaker SL, McIntosh K, Hughes MD, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219C Team.

Pediatrics. 2006 Feb;117(2):273-83.

PMID:
16452344
14.

Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.

Storm DS, Boland MG, Gortmaker SL, He Y, Skurnick J, Howland L, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Study Team.

Pediatrics. 2005 Feb;115(2):e173-82. Epub 2005 Jan 3.

PMID:
15629958
15.

Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life.

Nozyce M, Hittelman J, Muenz L, Durako SJ, Fischer ML, Willoughby A.

Pediatrics. 1994 Dec;94(6 Pt 1):883-91.

PMID:
7971006
16.

Teacher-assessed behavior of children prenatally exposed to cocaine.

Delaney-Black V, Covington C, Templin T, Ager J, Nordstrom-Klee B, Martier S, Leddick L, Czerwinski RH, Sokol RJ.

Pediatrics. 2000 Oct;106(4):782-91.

PMID:
11015523
17.

Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study.

Paul ME, Chantry CJ, Read JS, Frederick MM, Lu M, Pitt J, Turpin DB, Cooper ER, Handelsman EL.

Pediatr Infect Dis J. 2005 Jan;24(1):46-56.

PMID:
15665710
18.

Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study.

Pacheco SE, McIntosh K, Lu M, Mofenson LM, Diaz C, Foca M, Frederick M, Handelsman E, Hayani K, Shearer WT; Women and Infants Transmission Study.

J Infect Dis. 2006 Oct 15;194(8):1089-97. Epub 2006 Sep 11.

PMID:
16991083
19.

Does exposure to antiretroviral therapy affect growth in the first 18 months of life in uninfected children born to HIV-infected women?

Hankin C, Thorne C, Newell ML; European Collaborative Study.

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):364-70.

PMID:
16249713
20.

Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study.

Mussi-Pinhata MM, Freimanis L, Yamamoto AY, Korelitz J, Pinto JA, Cruz ML, Losso MH, Read JS; National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study Group.

Pediatrics. 2007 Mar;119(3):e694-704. Epub 2007 Feb 12.

PMID:
17296782

Supplemental Content

Support Center